Mounjaro is not approved for weight loss. It is approved only for uses that involve type 2 diabetes, so most people who want tirzepatide for weight are prescribed Zepbound instead: the same medicine, from the same maker, approved for weight management. Zepbound is also the cheaper of the two to buy without insurance: $299 to $449 a month on LillyDirect, against “as low as $499” for Mounjaro with Lilly’s savings card.
Here is why the two names exist, what changes between them, and how to get Zepbound if that is what you are after.
Same medicine, two approvals
Mounjaro and Zepbound both contain tirzepatide, made by Eli Lilly, at the same weekly doses from 2.5 mg to 15 mg. What separates them is what the FDA approved each one for.
Mounjaro is approved “as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus,” and to reduce the risk of heart attack, stroke and cardiovascular death in adults with type 2 diabetes who are at high risk of them (Mounjaro prescribing information, revised 8/2026). It has no weight-management indication.
Zepbound is approved, with diet and exercise, to reduce excess body weight and keep it off long term in adults with obesity, or with overweight plus at least one weight-related condition, and to treat moderate to severe obstructive sleep apnea in adults with obesity (Zepbound prescribing information).
A doctor can legally prescribe a medicine off-label, but the approval decides almost everything practical: what insurers cover, which savings programs apply, and which product the prescription is written for.
Why “Mounjaro for weight loss” usually ends in a denial
Insurers write their rules around the approval. UnitedHealthcare’s commercial policy, effective July 1, 2026, says Mounjaro and similar drugs “are only indicated for the treatment of type 2 DM and are not FDA approved for the treatment of weight loss,” and asks for medical records confirming type 2 diabetes (UnitedHealthcare policy). Lilly’s own Mounjaro savings card requires a prescription “for an approved use consistent with FDA approved product labeling” and commercial insurance (Mounjaro savings terms).
Medicare cannot pay for drugs used for weight loss at all under Part D, and Mounjaro is not one of the drugs in the temporary Medicare GLP-1 Bridge. How coverage works for people who do have type 2 diabetes is covered in does insurance cover Mounjaro?
What each costs without insurance
| Zepbound (vial or KwikPen) | Mounjaro (single-dose pen) | |
|---|---|---|
| Where | LillyDirect, self-pay | Retail pharmacy, with Lilly’s savings card |
| 2.5 mg | $299 | as low as $499 |
| 5 mg | $399 | as low as $499 |
| 7.5 mg to 15 mg | $449 if refilled within 45 days ($499 to $699 otherwise) | as low as $499 |
| Who can use it | anyone paying cash with a prescription | commercially insured, prescribed for an approved use, no government coverage |
Prices per four-week supply from LillyDirect and Mounjaro’s savings terms, checked October 18, 2026. Lilly’s savings cards end December 31, 2026. Needles and syringes are bought separately.
The full Zepbound breakdown, including what a year costs, is in how much is Zepbound without insurance?
Getting Zepbound through Gentle Health
We don’t prescribe Mounjaro. Our doctor prescribes brand-name Zepbound, as single-dose vials or the KwikPen, in all 41 jurisdictions where our physician is licensed.
- You complete the online intake. The doctor reviews it in writing, or by video visit where your state requires one.
- If Zepbound is right for you, the doctor sends the prescription to LillyDirect, Lilly’s own pharmacy service.
- LillyDirect texts and emails you how to check out, and you buy the medicine from them at the prices above.
You pay us $28/month for the doctor’s care, including messaging and video visits, and you pay only once the doctor writes the prescription. There is no minimum, and you can cancel any time. Gentle Health is not affiliated with Eli Lilly. How our care fee compares with other online providers is on our comparison page.
We also prescribe compounded tirzepatide, from $169 a month with the medication included. Compounded medications are not FDA-approved, and compounded tirzepatide is not a generic or an equivalent version of Mounjaro or Zepbound. If your plan covers Zepbound, that may cost you less than either option, and it is worth checking first.
Frequently asked questions
Is Mounjaro approved for weight loss? No. Mounjaro is approved to improve blood sugar control in type 2 diabetes and to lower cardiovascular risk in adults with type 2 diabetes. Zepbound, the same medicine, is the version approved for weight management.
Is Zepbound the same as Mounjaro? Both contain tirzepatide, are made by Eli Lilly and come in the same weekly doses. They have different approved uses, devices and prices, and insurers treat them as different products.
Can I get Mounjaro prescribed online for weight loss? A doctor can prescribe off-label, but insurers and Lilly’s savings card expect an approved use. Gentle Health prescribes Zepbound for weight rather than Mounjaro, because Zepbound is the version approved for it: we prescribe Zepbound for $28/month of doctor’s care, and you buy it from LillyDirect.
Is Zepbound cheaper than Mounjaro without insurance? Usually. Zepbound vials and KwikPens cost $299 to $449 a month on LillyDirect, against as low as $499 for Mounjaro with Lilly’s savings card, as of October 18, 2026.
I have type 2 diabetes. Which one is for me? That is your doctor’s decision. Mounjaro is the version approved for type 2 diabetes, and insurance is far more likely to cover it for that use.
Dr. James Simmons, MD